// App-Quantinova.ai

229 : A metabolic switch controls cell fate decision-making in intestinal differentiation downstream of the tumor suppressor adenomatous polyposis coli (apc)

Researchers

Presenter

  • Imelda T. Sandoval

Principal Investigators

  • Richard Glenn C. Delacruz

  • Braden N. Miller

  • Christeena Satterfield

  • Kristophor Olson

  • Shauna Hill

  • Holly Van Remmen

  • Jared Rutter

  • David A. Jones

Medical Centers

  • Functional and Chemical Genomics, Oklahoma Medical Research Foundation, Oklahoma City, OK

  • Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT

  • Free Radical Biology and Aging Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Familial adenomatous polyposis

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

  • Pyruvate

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved